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In 2009, a new influenza A (H1N1) virus affected many persons around the world. There is an urgent need for finding biomarkers
to distinguish between influenza A (H1N1)pdm09 and seasonal influenza virus. We investigated these possible biomarkers in the
lung of fatal cases of confirmed influenza A (H1N1)pdm09. Cytokines (inflammatory and anti-inflammatory) and cellular markers
(macrophages and lymphocytes subpopulation markers) were analyzed in lung tissue from both influenza A (H1N1)pdm09 and
seasonal influenza virus. High levels of IL-17, IFN-𝛾, and TNF-𝛼 positive cells were identical in lung tissue from the influenza A
(H1N1)pdm09 and seasonal cases when compared with healthy lung tissue (𝑃 < 0.05). Increased IL-4+ cells, and CD4+ and CD14+
cells were also found in high levels in both influenzaA (H1N1)pdm09 and seasonal influenza virus (𝑃 < 0.05). Low levels of CD206+
cells (marker of alternatively activatedmacrophagesmarker in lung) were found in influenza A (H1N1)pdm09when compared with
seasonal influenza virus (𝑃 < 0.05), and the ratio of CD206/CD14+ cells was 2.5-fold higher in seasonal and noninfluenza group
comparedwith influenza A (H1N1)pdm09 (𝑃 < 0.05). In conclusion, CD206+ cells differentiate between influenza A (H1N1)pdm09
and seasonal influenza virus in lung tissue of fatal cases.
1. Introduction
Influenza is a viral infectious disease recognized as a major
public health problem worldwide due to high morbidity and
mortality. Seasonal influenza causes more than 200,000 hos-
pitalizations and approximately 36,000 deaths each year in
theUnited States during the fall andwinter [1]. New influenza
virus outbreaks are expected every 8–41 years, similar to
influenza A (H1N1)pdm09 (2009). During these outbreaks,
more than 50% of the population could be infected due
to the high transmissibility of the virus. Severe pneumonia
is frequent in fatal cases of influenza A (H1N1)pdm09 [1]
and diffuse alveolar damage (DAD) has been reported in
83% of fatal cases of influenza A (H1N1)pdm09 [2]. Immune
response to influenza virus infection has been extensively
studied on blood samples from patients with moderate or
severe infection to explore severity markers. Previous studies
showed high levels of inflammatory cytokines in sera or
plasma, named “cytokine storm” or hypercytokinemia [3–5].
This exacerbated activation of the immune systemmay result
in acute lung injury and contribute to higher rates of fatal
cases. Early immune response to influenza A (H1N1)pdm09
in sera from hospitalized patients was characterized by Th1
and Th17 related cytokines, important mediator of cellular
immune response and inflammation [6]. Recently, high levels
of proinflammatory cytokine and chemokines were found in
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Figure 1: Representative examples of microscopic findings in the lung section of noninfected samples (×40).
lung tissues from fatal cases of influenza A (H1N1)pdm09;
it was one of a few reports in exploring the immunological
environment in the lung [7].
However, little is known about other cell populations, as
lymphocytes and macrophages in lung tissue of fatal cases,
as well as cytokine expression. In the present study, we
analyzed viral load, tissue damage, cytokines response, and
T lymphocytes and macrophages markers in lung tissues
from fatal cases of influenza A (H1N1)pdm09 and seasonal
influenza. Our results presented suggest that there are no
differences between influenza A (H1N1)pdm09 and seasonal
influenza in viral load, cytokines response, or T lymphocytes
markers but CD206 number differentiates between both
influenza A (H1N1)pdm09 and seasonal influenza.
2. Materials and Methods
2.1. Patients. A retrospective study was conducted on lung
tissue from 72 fatal cases suspected of influenza A infection
and antemortem diagnosis was pneumonia; two of them
had a positive PCR for pandemic influenza. These cases
were registered from August 2005 to December 2009. Five
noninfected samples were included in this study; they were
fatal cases of patients with carotid aneurysm, melanoma and
cervix, and kidney and liver cancer, where the lung tissues of
these patients show no inflammation (Figure 1). This study
was approved by the Bioethics Committee of the School
of Medicine at the Universidad Autonoma de Nuevo Leon
(UANL) number IN10-004.
2.2. Virus Detection. Total RNA was isolated from formal-
dehyde-fixed paraffin-embedded (FFPE) lung tissues. Eight
10 𝜇m slides were placed in a microtube RNases-free, and
RNA was extracted using RecoverAll Total Nucleic Acid Iso-
lation Kit (Ambion, Austin, TX) according to the manufac-
turer’s instructions. Finally, the concentration of RNA in each
sample was determined by spectrophotometry. Influenza A
[seasonal or (H1N1)pdm09] in samples was detected using
the CDC’s qRT-PCR protocol or PrimerDesign genesig Kit
for Swine H1N1 Influenza Human Pandemic Strain (H1N1-
swine) (Primer design, UK) following the manufacturer’s
protocol. PrimerDesign genesig Kit for SwineH1N1 Influenza
Human Pandemic Strain (H1N1-swine) also was used to
quantify the viral load as follows: 55∘C for 10 minutes, 95∘C
for 8 minutes, and 50 cycles of denaturation at 95∘C for
10 seconds, annealing and extension at 60∘C for 60 s. Reac-
tions were performed with 2𝜇L of total RNA (400 ng) extract
and Brilliant III Ultra-Fast QRT-PCR Master Mix (Agilent
Technologies, La Jolla, CA) on the CFX96 thermocycler (Bio-
Rad, Hercules, CA). Internal control (ACTB) was included
in real time qRT-PCR in each sample to verify that RNA
isolation and qRT-PCR were performed under the best con-
ditions. RNA concentrations ranges were from 145.8 𝜇g/mL
to 1881.2 𝜇g/mL; meanwhile, RNA purity was from 1.72 to
1.99 at 260/280 nm. Internal control amplified in all analyzed
samples.
2.3. Histopathology Analysis. Samples were processed using
standard histological protocols. Histopathological evaluation
was done in tissue sections from each sample stained with
hematoxylin and eosin (H&E), and lung injury score was
registered as previously described [8]. Two blinded expert
pathologists analyzed ten different fields of each individual
sample at 40x and the average of the score was obtained from
each sample.
2.4. In Situ Detection of Cytokines and Cells Markers. Paraffin
embedded blocks from lung of fatal cases of influenza A
patients and noninfected groups were cut in 5–7𝜇m sec-
tions. The sections were prepared for immunohistochem-
istry (IHC) using standard protocols. The slides were incu-
bated overnight at 4∘C with a primary antibody against
human cytokines (IL-4, IL-10, IL-17, IFN-𝛾, and TNF-𝛼)
or macrophages (CD14 was used for general macrophages
population marker and CD206 for alternatively activated
macrophages “AAM”) and lymphocytes populations (CD4
was used for T helper cells, CD8 for T cytotoxic cells,
and FOXP3 for T regulatory) markers; list of antibodies is
presented in Table 1. Thereafter, with another biotinylated
secondary antibody, samples were incubated during 1 h at
RT. The specific antibody binding reaction was amplified
by incubation with ABC development system (Vector Lab,
Burlingame, CA) during 30min at RT. After the amplification
step, the slides were washed and incubated again for 3min
with the chromogen substrate forHRP 3,3-diaminobenzidine
(DAB) (Vector Lab, Burlingame, CA). Finally, the slides were
counterstained using hematoxylin andmounted using Vecta-
Mount (Vector Lab, Burlingame, CA). The total positive cells
were counted within ten different observation fields at 40x.
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Figure 2: Similar lung injury scores were found in influenza groups. (a)–(c) H&E stain of three studied groups where tissue damage was
evident in influenza groups. 𝑃 < 0.05, Kruskal-Wallis test. (d) Tissue damage score showed no significant differences between influenza
groups.
Table 1: List of antibodies used to detect cytokines and cellular
markers.
Antibodies Dilution Company
Rabbit polyclonal IgG anti-IL-4 0.25 𝜇g PeproTech
Rabbit polyclonal IgG anti-IL-10 2.5 𝜇g PeproTech
Rabbit polyclonal IgG anti-IL-17 1 : 100 Santa Cruz
Rabbit polyclonal IgG anti-IFN-𝛾 1 : 100 Santa Cruz
Rabbit polyclonal IgG
anti-FOXP3 1 : 400 Santa Cruz
Rabbit polyclonal IgG
anti-TNF-𝛼 1 : 400 Abcam
Goat polyclonal IgG anti-CD4 5 𝜇g R&D Systems
Mouse monoclonal IgG1
anti-CD8 1 : 50 Santa Cruz
Goat polyclonal IgG anti-CD14 2𝜇g Abcam
Goat polyclonal IgG anti-CD206 5 𝜇g R&D Systems
Then, the mean of positive cells per field for each sample was
calculated.
2.5. Statistical Analysis. The Kruskal-Wallis test was used for
statistical comparisons of multiple data groups. The Mann-
Whitney two-tailed unpaired 𝑈-test was used for statistical
comparisons of two data. Calculations were performed using
GraphPad Prism version 5.0 for Windows (San Diego, CA,
USA). 𝑃 values < 0.05 or less were considered significant.
3. Results and Discussion
3.1. Study Groups and Virus Detection. 72 fatal cases
were analyzed by qRT-PCR for seasonal and influenza A
(H1N1)pdm09. Ten patients with influenza A were detected
by qRT-PCR; four of them had influenza A (H1N1)pdm09.
Females represented 25% of the fatal cases of influenza A
(H1N1)pdm09, 83% of the seasonal influenza A, and 20%
of the noninfected groups. The median age was 31.7 ± 8.75
years (range, 23–37 years) in influenza A (H1N1)pdm09
group, 37.8 ± 34.2 years (range, 24–72 years) in seasonal
influenza A group, and 41.8 ± 23.3 years (range, 30–65
years) in noninfected group. Smoking was the comorbidity
most frequent in fatal cases by influenza A virus followed
by obesity and diabetes mellitus in the same percentages;
see Table 2. Smoking, diabetes mellitus, and obesity are risk
factors previously reported to influenza virus susceptibility
[9, 10]. Recent study shows strong evidence of the fact that
cigarette smoke extract inhibits RIG-I, IFN-𝛽, and IP-10; all
of them participate in innate immune response to influenza
production in human lung and this may be involved in
influenza susceptibility [11].
The viral loads ranged from 2 to 138 copies of RNA;
M1 or N1 transcript standard curves were used for quan-
titative detections of influenza A (H1N1)pdm09 and sea-
sonal influenza A virus, respectively. Recently, researchers
detected influenza virus RNA from FFPE tissues obtained
from autopsies using real time RT-PCR [7]. In our study,
we also detected influenza virus RNA using a similar
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Figure 3: Predominant inflammatory environment cytokines were detected in influenza groups. High levels of IL-4, IL-17, IFN-𝛾, and TNF-𝛼
were found in lung from influenza A infected patients; meanwhile, significant differences were found in IL-10 levels (×40).
Table 2: Demographic characteristics and comorbidities identified
in the influenza A patients.
Patients ID Age Sex Comorbidity
Seasonal influenza A patients
4555 29 Female Hepatitis
4586 72 Female Chronic cardiopathy
4798 36 Male Smoking/obesity
4807 24 Female Smoking/diabetes mellitus
4817 29 Female Unknown
4824 37 Female Diabetes mellitus
Influenza A (H1N1)pdm09 patients
4814 37 Female Unknown
4823 23 Male Smoking
4826 35 Male Morbid obesity
N-13-09 31 Male Smoking
total RNA extraction kit and protocol for FFPE tissues
obtained from autopsies from fatal cases suspected of
influenza A infection. These findings open a new approach
to study influenza virus in suspected samples, as well as
the pathogenesis and infection biomarkers in human lung
tissue. Studies have reported the viral load in peripheral
blood, mononuclear cells, or lung aspirates from influenza
virus infected patients; however, none included lung tissue
[12, 13].
3.2. Lung Injury Score Was Not Different in Both Influenza A
(H1N1)pdm09 and Seasonal Influenza AVirus. Lung injury is
present in influenza infection [14], and similar findings were
found in influenza groups as visualized in Figures 2(b)-2(c).
We questioned if lung injury levels may distinguish between
both influenza A (H1N1)pdm09 and seasonal influenza
A virus infection. Hemorrhage, interstitial infiltrates, and
perivascular aggregates were analyzed in studied groups to
complete injury score. High lung injury score was found in
both influenza A (H1N1)pdm09 and seasonal influenza A
virus; samples were compared with noninfected lung (𝑃 <
0.05); however, no differences were found between influenza
groups (𝑃 > 0.05) (Figure 2(d)).
3.3. Inflammatory Cytokines Were Detected in Lung Tissue.
High levels of cytokine production have been previously
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Figure 4: CD4+ and CD14+ cells were highly recruited in the lung of fatal cases of influenza. Representative microphotography of CD8,
Foxp3, CD4, and CD14 immunohistochemistry in lung tissue of noninfected, influenza A (H1N1)pdm09, and seasonal influenza (×40). No
differences were found in CD8+ cells and Foxp3+ cells. High levels of CD4+ and CD14+ cells were found in lung of influenza groups.
reported in sera of severe cases of influenza A [11, 12]; we
question if similar findings were occurring in lung tissue
of fatal cases of influenza A and if it may be similar in
influenza groups. We evaluated the inflammatory and anti-
inflammatory cytokine levels. High levels of IL-17, IFN-𝛾, and
TNF-𝛼 were found in influenza samples when compared to
noninfected lung (𝑃 < 0.003, 𝑃 = 0.008, and 𝑃 = 0.009, resp.,
Kruskal-Wallis test). No differences were found between
those cytokines levels between influenza A (H1N1)pdm09
and seasonal influenza A virus samples (𝑃 > 0.05) (Figure 3).
The role of IL-17 and IL-17RA in acute lung injury, morbidity,
andmortality induced by influenza A virus has been reported
[2, 13]. In this study, IL-17A was elevated in influenza groups,
and these data suggest that IL-17 released by both local and
recruited cells into the lung may contribute to the acute lung
injury and patient’s outcomes. In Brazil, researchers found
strong expression of IFN-𝛾 and TNF-𝛼 in lung of fatal cases
of influenza A (H1N1)pdm09 [15]. In agreement with our
results, high levels of TNF-𝛼were found in blood in three fatal
cases of influenza A (H1N1)pdm09; the same phenomenon
was reflected in lung tissue [15]. IL-17, IFN-𝛾, and TNF-𝛼
high levels are a solid evidence of the strong inflammatory
response in lung from influenza infected patients; all these
findings may be involved with fatal outcome.
IL-4 is a cytokine related to AAM and Th2 response
[16]; in our study, we found that cytokine was elevated in
both influenza A (H1N1)pdm09 and seasonal influenza A
virus (𝑃 = 0.036, Kruskal-Wallis test) (Figure 3). Similar
results were found in plasma of patients infected with
influenza A (H1N1)pdm09 and seasonal influenza A [17,
18]. Differences in these results may be related to used
samples (sera, plasma, and lung tissue) and sample size.
Moreover, lung tissue environment reflects the real envi-
ronment of influenza infection. IL-10 is an immunoregu-
latory cytokine and downregulates inflammatory response
[19]; however, no differences were found in IL-10 level
in groups included in this study (𝑃 > 0.05, Kruskal-
Wallis test) (Figure 3). Our results suggest that the strong
inflammatory response is not controlled by IL-10 in lung from
influenza patients andmay contribute to lung injury and fatal
outcome.
3.4. CD4+ and CD14+ Are Recruited in Patient’s Lung Tissue
with Influenza A (H1N1)pdm09 and Seasonal Influenza A
Virus. Although recruitment of neutrophils into the lung
during influenza infection has been described, other reports
have detected presence of lymphocytes population [20].
We question if there are differences in lymphocyte and
macrophage subpopulations number in influenza groups,
and to answer that question, we analyzed macrophages
and lymphocytes markers in studied groups. CD8+IFN-
𝛾+ lymphocytes have been implicated in protection against
symptomatic pandemic influenza [21]. No differences were
found in CD8+ cell number in fatal cases of influenza A
(H1N1)pdm09, seasonal influenza A virus, and noninfected
samples (𝑃 > 0.05, Kruskal-Wallis test) (Figure 4). These
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Figure 5: Increased CD206+ cells were found in influenza A (H1N1)pdm09. Representative microphotography of CD206 immunohisto-
chemistry in lung tissue of (a) control, (b) noninfected, (c) influenza A (H1N1)pdm09, and (d) seasonal influenza (×40). (e) CD206+ cells
were statistically significant between influenza groups.
findings may explain in part why those patients succumbed
to influenza infection. CD4(+) CD25(+) Foxp3+ regulatory
T (Treg) lymphocyte populations are able to produce IL-10
[22]; however, in this study, IL-10 levels were not different
between influenza and noninfected groups (𝑃 = 0.12,
Kruskal-Wallis test). We evaluated Foxp3 marker in lung
tissue from influenza patients and no differences were found
in Foxp3 marker in the lung of influenza groups (𝑃 >
0.05) (Figure 4). High levels of peripheral CD4(+) CD25(+)
Foxp3+ regulatory T (Treg) cells have been found in influenza
A (H1N1)pdm09 [23], but in our findings, in the lung tissue,
these lymphocyte populations are not increased (Figure 4).
Virus specific CD4+ lymphocytes may be recruited in lung
tissue [24]; here, in the present study, high levels of recruited
CD4+ cells were found in influenza groups compared with
noninfected tissue (𝑃 = 0.007, Kruskal-Wallis test), but
no differences were found between fatal cases of influenza
(𝑃 > 0.05) (Figure 4). CD4+ lymphocytes (Th1, Th2, and
Th17) are producers of IFN-𝛾, IL-4, and IL-17, respectively
[25]. Increased CD4+ and high levels of cytokines in lung of
influenza patients support the strong inflammatory response,
where Th1, Th2, and TH17 may be involved in lung injury.
Patients with severe influenza A (H1N1)pdm09 infection
presentTh1 andTh17 hypercytokinemia in sera [6]; however,
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Figure 6: Low ratio of CD206/CD14 was found in influenza A
(H1N1)pdm09 group.
this study shows evidence that Th2 response is present in
the lung together with Th1 and Th17. High levels of CD14+
macrophages were recruited in lung of fatal cases of influenza
groups (𝑃 = 0.001, Kruskal-Wallis test); however, no
differences were found between fatal cases of influenza A
(H1N1)pdm09 and seasonal influenza A virus (𝑃 > 0.05)
(Figure 4). A report suggested that CD14 has a limited role in
host immune response to influenza virus infection; however,
here CD14+ cells were recruited in the lung of infected
patients suggesting that CD14+ cells may be producing
inflammatory cytokine and in this way contributing to tissue
injury as described by Pauligk et al. [26].
3.5. CD206+ Cells Differentiate Influenza A (H1N1)pdm09
from Seasonal Influenza A Virus. Alveolar macrophages
express predominantly an M2 phenotype [27]; CD206 is a
characteristic surface marker of M2 macrophages, which has
been reported in alveolar macrophages [28]. Interestingly,
CD206+ cells were found in lower levels in influenza A
(H1N1)pdm09 fatal cases than seasonal influenza A (𝑃 =
0.0007, Kruskal-Wallis test) (Figure 5). Macrophages M2 are
producers of cytokines such as IL-4/IL-13 or IL-10/TGF𝛽;
despite the lack of difference found in IL-10 level, a report
described that IL-10 and TGF𝛽 are necessary to improve the
outcome in mice [29]. Depletion of alveolar macrophages
can lead to an exacerbated inflammatory process and it is
recognized that the mainmechanism is the lacking of control
of this process [30].
3.6. Imbalance of CD206 and CD14 Cells Was Found in
Lung Tissue of Fatal Cases of Influenza A (H1N1)pdm09. In
different studies, imbalance betweenM1 andM2 populations
of macrophages has been associated with a worse prognosis
in animal models [31]. Imbalance between CD206+ and
CD14+ cells was evaluated assessing their ratio in lung of
fatal cases of influenza. CD206/CD14+ cells ratio was 2.5-fold
higher in seasonal and noninfected group than in influenza
A (H1N1)pdm09 (𝑃 = 0.01, Kruskal-Wallis test) (Figure 6).
These data suggest that there are no enough recruited healing
macrophages in the lung tissue of influenza A (H1N1)pdm09
patients and this may favor inflammatory response and lung
injury.
4. Conclusion
In this study, we demonstrated for the first time that recruited
CD4+ and CD14+ cells are present in lung tissue and many
may be responsible of cytokine production and in conse-
quence lung injury in both influenza A (H1N1)pdm09 and
seasonal influenza A virus in fatal cases. CD206 expression
was reduced exclusively in influenza A (H1N1)pdm09; we
propose that it may be used as potential biomarker to
pandemic influenza and other cytokines markers may work
for future therapy in severe cases of influenza A.
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